News

News Feb 21, 2025

This Week in Drug Pricing: DOJ Defends Medicare Negotiations, Push For Competition Bills & Defending Medicare Negotiations, Drugmakers Meet With President Trump — Patients Excluded, and ICYMI

The Trump Department of Justice (DOJ) took the first step in defending Medicare negotiation in court.

Read Article News Feb 14, 2025

This Week in Drug Pricing: P4AD Report Debunks Drug Industry Myths About IRA, RFK Jr. Selected As HHS Secretary, Rising Cost of Cell And Gene Therapies and ICYMI

This week, P4AD released a report dismantling Big Pharma’s false claims about the 2022 prescription drug law, highlighting how the law is already lowering costs for patients and taxpayers.

Read Article News Feb 7, 2025

This Week in Drug Pricing: New Bills Attempt To Weaken The IRA, Price Hikes On 15 Drugs Selected For Medicare Negotiation, Americans Demand Health Care Affordability, Big Pharma’s Big Earnings, and ICYMI

P4AD sent a letter to all members of the House of Representatives yesterday, opposing two bills that would weaken the Medicare Drug Price Negotiation Program – a critical lever that will lower drug…

Read Article News Jan 31, 2025

This Week in Drug Pricing: Trump Administration Continues Medicare Negotiation, US v. Pharma: Patient-Led Petition Delivery, HHS Secretary Confirmation Hearings, and ICYMI

In a promising sign for patients, the Centers for Medicare and Medicaid Services (CMS) confirmed that the Medicare Drug Price Negotiation Program remains on track, marking a critical moment for the…

Read Article News Jan 24, 2025

This Week in Drug Pricing: US v. Pharma, Trump Administration’s First Drug Pricing Action, $2k OOP Cap Brings Transformative Relief, and ICYMI

Patients For Affordable Drugs filed a patient-focused amicus brief in the Second Circuit Court of Appeals, opposing Boehringer Ingelheim’s lawsuit to block Medicare negotiation.

Read Article News Jan 17, 2025

This Week in Drug Pricing: CMS announces next 15 negotiated drugs, Teva joins Big Pharma’s assault on Medicare negotiation, FTC report exposes PBM price gouging scheme, and P4ADNOW debunks Pharma misinformation.

Marking another historic step for patients, the Centers for Medicare & Medicaid Services (CMS) announced the next 15 drugs selected for Medicare negotiation.

Read Article News Jan 10, 2025

This Week in Drug Pricing: Big Pharma’s Price hikes Kick Off 2025, The Next 15 Drugs, $2,000 Cap On OOP Costs In Effect, and ICYMI

Big Pharma is ringing in the New Year with more than 250 planned price hikes on essential medicines with median increases of 4.5% – well above the 2.7% inflation rate.

Read Article News Jan 3, 2025

The Year in Review in Prescription Drug Pricing

Over the last 12 months, our community of hundreds of thousands of patients and allies has taken action to protect the historic 2022 prescription drug law, debunk Big Pharma’s propaganda, and…

Read Article News Dec 21, 2024

Patients For Affordable Drugs Now Expresses Outrage As Drug Price Provisions Are Left Out Of Continuing Resolution Due To Last-Minute Politics

Patients For Affordable Drugs Now expresses deep disappointment and frustration over the failure to include key drug pricing reforms in the end-of-year continuing resolution (CR) despite strong bipartisan support.

Read Article News Dec 20, 2024

This Week in Drug Pricing: End-Of-Year Spending Bill And Key Drug Price Reforms Still In Flux, Court Watch: US V. Pharma, and ICYMI

In a turbulent week of negotiations, House leadership continues to grapple with internal divisions and external political pressures ahead of tonight’s midnight government funding deadline.

Read Article